If you need treatment now, semaglutide and tirzepatide are excellent options with strong data behind them
Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: a systematic review and meta-analysis of randomized controlled trials
Dose-dependent effects: CBDAs pharmacology can vary with concentration, as with CBGA, requiring careful characterization in future studies
Strengthened Enforcement: The Central Drugs Standard Control Organisation(CDSCO) must move from reactive raids to a proactive system for tracking Schedule-H drugs, possibly using blockchain or a centralized digital prescription registry
"There'll be patients that need to continue [semaglutide injections] at the same dose indefinitely," Houston Methodist's Dr
Retatrutides glucagon receptor activity may increase energy expenditure and influence fat metabolism, although it can also affect heart rate and gastrointestinal tolerance in some individuals